Micro-X Ltd
ASX:MX1
Micro-X Ltd
ASX:MX1
Price:
0.09 AUD
-4.26%
Market Closed
Updated:
May 3, 2024
Micro-X Ltd
Operating Income
|
Micro-X Ltd
Operating Income Peer Comparison
Comparables:
NTI
IPD
C
CYC
COH
EMV
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Micro-X Ltd
ASX:MX1
|
Operating Income
-AU$14.3m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Neurotech International Ltd
ASX:NTI
|
Operating Income
-AU$7.8m
|
CAGR 3-Years
-82%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Operating Income
-AU$20.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-12%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Operating Income
-AU$8.6m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-119%
|
CAGR 10-Years
-25%
|
|
|
Cochlear Ltd
ASX:COH
|
Operating Income
AU$491.1m
|
CAGR 3-Years
36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
15%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Operating Income
-AU$3.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
See Also
What is Micro-X Ltd's Operating Income?
Operating Income
-14.3m
AUD
-14.3m
AUD
Based on the financial report for Dec 31, 2023, Micro-X Ltd's Operating Income amounts to -14.3m AUD.
What is Micro-X Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
3%
3%
Over the last year, the Operating Income growth was -20%. The average annual Operating Income growth rates for Micro-X Ltd have been -14% over the past three years , 3% over the past five years .
You don't have any saved screeners yet
